share_log

新天地(301277.SZ)：药品生产许可证变更 主要涉及增加委托生产

Xintiandi (301277.SZ): Pharmaceutical production license changes mainly involve increasing commissioned production

Gelonghui Finance ·  May 21 15:56

Gelonghui, May 21丨Xintiandi (301277.SZ) announced that the company (hereinafter referred to as the “Company”) recently obtained a “Pharmaceutical Production License” issued by the Henan Drug Administration and agreed to the “Pharmaceutical Production License” change application. This change mainly involves an increase in contract production; other details remain unchanged.

New entrustment items:

Trustee company: Baizheng Pharmaceutical Co., Ltd.; Commissioned variety: moxifloxacin hydrochloride tablets (specification: 0.4g); commissioned production address: No. 3888, Xuyou East Road, Dongcheng District, Xuchang City; commissioned production workshop and production line: tablet workshop, general production line. (Use only at the drug registration stage).

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment